Cargando…

A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy

Introduction. Gemcitabine and cisplatin (GC) is a gold-standard first-line systemic chemotherapy for advanced urothelial carcinoma (UC). However, it may cause severe adverse effects such as renal toxicity, gastrointestinal toxicity, and neurotoxicity. Sarcopenia is the age-related loss of skeletal m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasahara, Ryo, Kawahara, Takashi, Ohtake, Shinji, Saitoh, Yoko, Tsutsumi, Sohgo, Teranishi, Jun-ichi, Miyoshi, Yasuhide, Nakaigawa, Noboru, Yao, Masahiro, Kobayashi, Kazuki, Uemura, Hiroji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406717/ https://www.ncbi.nlm.nih.gov/pubmed/28497065 http://dx.doi.org/10.1155/2017/7981549

Ejemplares similares

Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy
por: Ohtake, Shinji, et al.
Publicado: (2016)

A low psoas muscle volume correlates with a longer hospitalization after radical cystectomy
por: Saitoh-Maeda, Yoko, et al.
Publicado: (2017)

A lower psoas muscle volume was associated with a higher rate of recurrence in male clear cell renal cell carcinoma
por: Noguchi, Go, et al.
Publicado: (2020)

A lower psoas muscle index predicts a poorer prognosis in metastatic hormone‐naïve prostate cancer
por: Iwamoto, Genta, et al.
Publicado: (2020)

Ureter metastatic castration-resistant prostate cancer: a case report
por: Tsutsumi, Sohgo, et al.
Publicado: (2017)

Skene duct adenocarcinoma in a patient with an elevated serum prostate-specific antigen level: a case report
por: Tsutsumi, Sohgo, et al.
Publicado: (2018)

A novel prediction model for the completion of six cycles of radium-223 treatment and survival in patients with metastatic castration-resistant prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2021)

Xanthogranulomatous Pyelonephritis with Incomplete Double Ureter
por: Hayashi, Yutaro, et al.
Publicado: (2017)

Foreign body in the bladder: A case report
por: Shimokihara, Kota, et al.
Publicado: (2017)

Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib
por: Kawahara, Takashi, et al.
Publicado: (2019)

Prognostic value of automated bone scan index for predicting overall survival among bone metastatic castration resistant prostate cancer patients treated with radium‐223
por: Miyoshi, Yasuhide, et al.
Publicado: (2020)

Ductal Adenocarcinoma of the Prostate: A Case Report
por: Hayashi, Yutaro, et al.
Publicado: (2016)

Renal Cell Carcinoma in a Horseshoe Kidney Treated with Laparoscopic Partial Nephrectomy
por: Ohtake, Shinji, et al.
Publicado: (2018)

Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
por: Noguchi, Go, et al.
Publicado: (2018)

Fluorescent Light-Guided Cystoscopy with 5-ALA Aids in Accurate Surgical Margin Detection for TURBO: A Case Report
por: Takamoto, Daiji, et al.
Publicado: (2018)

Prognosis and safety of radium‐223 with concurrent abiraterone acetate or enzalutamide use for metastatic castration‐resistant prostate cancer: Real‐world data of Japanese patients
por: Miyoshi, Yasuhide, et al.
Publicado: (2020)

PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer
por: Kawahara, Takashi, et al.
Publicado: (2018)

Onco-testicular sperm extraction (onco-TESE) for bilateral testicular tumors: two case reports
por: Tsutsumi, Sohgo, et al.
Publicado: (2017)

Successful Resection of Cisplatin-Resistant Renal Pelvic Cancer after the Administration of Pembrolizumab as Second-Line Therapy
por: Kawahara, Takashi, et al.
Publicado: (2019)

The Pretherapeutic Neutrophil-to-Lymphocyte Ratio for Docetaxel-Based Chemotherapy Is Useful for Predicting the Prognosis of Japanese Patients with Castration-Resistant Prostate Cancer
por: Tatenuma, Tomoyuki, et al.
Publicado: (2019)

Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy
por: Kawahara, Takashi, et al.
Publicado: (2016)

Enterogenous cyst of pediatric testis: a case report
por: Saitoh, Yoko, et al.
Publicado: (2017)

A high serum dehydroepiandrosterone concentration is a predictor of candidates for active surveillance in men with serum prostate-specific antigen < 10 ng/mL
por: Miyoshi, Yasuhide, et al.
Publicado: (2022)

Primary amelanotic malignant melanoma of the male urethra with inguinal lymph node metastasis successfully controlled by nivolumab: A case report
por: Tokita, Takashi, et al.
Publicado: (2018)

Impact of depression on overactive bladder
por: Kawahara, Takashi, et al.
Publicado: (2020)

Early assessment with (18)F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab
por: Tabei, Tadashi, et al.
Publicado: (2019)

Inflammatory Myofibroblastic Tumor in the Bladder: A Case Report
por: Kondo, Takuya, et al.
Publicado: (2016)

Port site recurrence after laparoscopic radical nephrectomy: a case report
por: Shimokihara, Kota, et al.
Publicado: (2017)

Efficacy of Immediate Switching from Bicalutamide to Flutamide as Second-Line Combined Androgen Blockade
por: Yokomizo, Yumiko, et al.
Publicado: (2016)

The Achievement of Long-Term CRPC Control in a Patient with Enzalutamide-Induced Nausea and Fatigue after Overcoming the Adverse Events with a Temporary Drug Holiday
por: Kawahara, Takashi, et al.
Publicado: (2019)

Clinical outcome of surgical management for symptomatic metastatic spinal cord compression from prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2020)

Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia
por: Kawahara, Takashi, et al.
Publicado: (2019)

Sarcomatoid Variant of Bladder Carcinoma: A Case Report
por: Uemura, Koichi, et al.
Publicado: (2018)

Risk Factors for Metastatic Castration-Resistant Prostate Cancer (CRPC) Predict Long-Term Treatment with Docetaxel
por: Kawahara, Takashi, et al.
Publicado: (2012)

Lenalidomide decreased the PSA level for castration‐resistant prostate cancer: a case report
por: Shimokihara, Kota, et al.
Publicado: (2018)

The neutrophil-to-lymphocyte ratio (NLR) predicts adrenocortical carcinoma and is correlated with the prognosis
por: Mochizuki, Taku, et al.
Publicado: (2017)

Functional paraganglioma of the bladder: Both radiographic‐negative and laboratory‐negative case
por: Sugimura, Rumiko, et al.
Publicado: (2019)

Successful treatment with sorafenib for sunitinib‐refractory metastatic papillary renal cell carcinoma: Potential impact of Raf overexpression on predicting the efficacy of sorafenib
por: Morinaga, Ryota, et al.
Publicado: (2018)

A low psoas muscle volume is associated with a poor prognosis in penile cancer
por: Takkamoto, Daiji, et al.
Publicado: (2020)

Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer
por: Kawahara, Takashi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kl8tjb0j6unflducvk63vgi9eg